Ropes & Gray represented GHO Capital Partners and Ampersand Capital Partners in the transaction, and Cooley represented Avid Bioservices, Inc. GHO Capital Partners, LP (“GHO Capital”),...
GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
MiddleGround Capital’s Acquisition of The L.S. Starrett Company
Dechert advised MiddleGround Capital, while Ropes & Gray served as legal counsel to Starrett on the deal. MiddleGround Capital, a private equity firm, announced their definitive...
LianBio’s License Agreement with Bristol Myers Squibb
Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
Eli Lilly’s Acquisition of Sigilon Therapeutics
Morgan, Lewis & Bockius acted as legal counsel to Eli Lilly, and Ropes & Gray acted as legal counsel to Sigilon. Eli Lilly and Company (NYSE:...
BP’s $1.3 Billion Acquisition of TravelCenters of America
Jones Day advised Citigroup on the deal while Ropes & Gray advised TravelCenters of America Inc. (TA). TravelCenters of America Inc. (Nasdaq: TA), the nationwide operator...
GI Partners’ $1.05 Billion Acquisition of Atlas Technical Consultants
Ropes & Gray LLP advised GI Partners, and Kirkland & Ellis LLP and Potter Anderson & Corroon LLP advised Atlas on the deal. Latham & Watkins...
Rallybio’s $50 Million Common Stock Offering
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
Blackstone’s $1 Billion Financing Collaboration with PTC Therapeutics
WilmerHale advised PTC Therapeutics, while Ropes & Gray advised Blackstone on the deal. Blackstone announced a strategic financing collaboration for up to $1 billion in funding...
Patient Square Capital and Gurnet Point Capital’s $890 Million Acquisition of Radius Health
Kirkland & Ellis advised Patient Square Capital, Ropes & Gray advised Radius, Latham & Watkins advised Gurnet Point Capital, Covington & Burling served as OrbiMed’s legal...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
U.S. AutoForce’s Acquisition of Max Finkelstein
Ropes & Gray advised Max Finkelstein Inc. in the transaction. Max Finkelstein Inc. executed its sale to U.S. AutoForce and will operate as a division of...